Novel asymmetrically engineered antibody Fc variant with superior FcγR binding affinity and specificity compared with afucosylated Fc variant

Fc engineering is a promising approach to enhance the antitumor efficacy of monoclonal antibodies (mAbs) through antibody-dependent cell-mediated cytotoxicity (ADCC). Glyco- and protein-Fc engineering have been employed to enhance FcγR binding and ADCC activity of mAbs; the drawbacks of previous app...

Descripción completa

Detalles Bibliográficos
Autores principales: Mimoto, Futa, Igawa, Tomoyuki, Kuramochi, Taichi, Katada, Hitoshi, Kadono, Shojiro, Kamikawa, Takayuki, Shida-Kawazoe, Meiri, Hattori, Kunihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893233/
https://www.ncbi.nlm.nih.gov/pubmed/23406628
http://dx.doi.org/10.4161/mabs.23452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893233/
https://www.ncbi.nlm.nih.gov/pubmed/23406628
http://dx.doi.org/10.4161/mabs.23452

Ejemplares similares